300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Oil and Gas
Payments
Retail
Film
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Tunisia
Taiwan
Zimbabwe
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Armenia
Colombia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
Seychelles
Botswana
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Bangladesh
Angola
Europe
Cyprus
Qatar
Barbados
Belgium
Azerbaijan
Austria
Ethiopia
Jordan
Ecuador
Bahamas
Bulgaria
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Bahrain
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Jersey
Estonia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
Ukraine
San Marino
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

Zhangjiang Science & Technology Investment Corporation

VC Fund

Zhangjiang, China

Zhangjiang Science & Technology Investment Corporation is a VC fund in Zhangjiang focused on Medical and Health Care. Shanghai Zhangjiang Science & Technology Investment Corporation (ZJ STIC) was founded in 2005. The Company is the investment strategy arm of Zhangjiang High-tech Park.

Total investments:
32
Last investment:
Lead investor:
28%

Last updated:

Industries Zhangjiang Science & Technology Investment Corporation invests in

MedicalHealth CareManufacturingSoftwareBiopharma

Stages Zhangjiang Science & Technology Investment Corporation invests in

Series AAngelSeries BSeedSeries E

Countries Zhangjiang Science & Technology Investment Corporation invests in

ChinaSwitzerlandUnited States

Contacts

NameEmailPhoneSocials
Sun Weiqin

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Medical 5 (16%)
  • Health Care 5 (16%)
  • Manufacturing 5 (16%)
  • Software 4 (13%)
  • Biopharma 4 (13%)
See all 49 industries →

Stage

  • Series A 13 (41%)
  • Angel 9 (28%)
  • Series B 6 (19%)
  • Seed 2 (6%)
  • Series E 1 (3%)
See all 6 stages →

Country

  • China 29 (91%)
  • Switzerland 1 (3%)
  • United States 1 (3%)

Team

NameTitleInvestmentsLinksEmail
Sun Weiqin General Manager
General Manager Total investments: 1 Find email

Investments

CompanyDescriptionRoundLinks
Phil Rivers Technology Phil Rivers Technology
Zheyuan Technology is an AI pharmaceutical R&D solution provider. $29.6M / Series A / Aug 05, 2026
TranscEngram TranscEngram
TranscEngram is an AI research and technology company focused on advancing artificial intelligence. Angel / Jul 05, 2026
Bivision Bivision
Biovision Pharma is a biomedical enterprise focusing on the research and development of targeted radiopharmaceuticals (TRT) integrated with visual diagnosis and treatment. $58.8M / Series B / May 18, 2026
Jinnao Medical Jinnao Medical
Jinnao Medical is a high-tech enterprise specializing in the research and development of invasive brain-computer interface (BCI) technology, focusing on the design, engineering, and commercialization of advanced neural interface systems that enable direct communication between the human brain and external devices, with applications spanningneurological disorder treatment, rehabilitation, and next-generation human–machine interaction. Angel / Apr 27, 2026
Optical Standard Technology Optical Standard Technology
Optical Standard Technology focuses on the design and manufacture of optical computing chips and optical computing boards for use in scenarios requiring large amounts of AI computing power, such as large model reasoning and training, autonomous driving, smart cities, quantitative finance, AI security. Venture - Series Unknown / Jul 07, 2025
Kepler Robotics Kepler Robotics
Kepler Robotics is a high-tech innovative enterprise focusing on the research and development, production and application ecology of general humanoid robots. Seed / Apr 24, 2025
Fourier Intelligence Fourier Intelligence
Fourier Intelligence is a Shanghai-based technology and design company providing exoskeleton robotic product and service on rehabilitation & orthoses. Its products include upper-limb rehab robotics and lower-limb exoskeleton robot, which can help the disabled go beyond of the physical limits, stand up and walk again. Its exoskeleton productscan also decrease fatigue and increase productivity whilst unloading supplies or enabling workers/soldiers to carry heavy objects. Series E / Jan 07, 2025
NK CellTech NK CellTech
NK CellTech is a biotechnology company that specializes in the development of innovative technologies for the treatment of NK cell therapy. Series A / Nov 22, 2024
Di-Matrix Di-Matrix
Di-Matrix is an IT firm that offers cloud based enterprise software solutions. $13.8M / Series B / Nov 15, 2023
Open Source China Open Source China
Open Source China is a software open source technology community. The community has formed several major channel contents such as open source software libraries, code sharing, information, collaborative translation, discussion forums, and blogs. Users can discover, use, and exchange open source technologies through the community. It also providestechnical questions and answers, software information and other services. $107.1M / Series B / Jun 26, 2023
See all 32 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Oil and Gas
Payments
Retail
Film
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Tunisia
Taiwan
Zimbabwe
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Armenia
Colombia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
Seychelles
Botswana
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Bangladesh
Angola
Europe
Cyprus
Qatar
Barbados
Belgium
Azerbaijan
Austria
Ethiopia
Jordan
Ecuador
Bahamas
Bulgaria
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Bahrain
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Jersey
Estonia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
Ukraine
San Marino
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Zhangjiang Science & Technology Investment Corporation invest in?

Zhangjiang Science & Technology Investment Corporation invests primarily in Medical, Health Care and Manufacturing startups, most often at Series A and Angel stage. Most of the 32 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Zhangjiang Science & Technology Investment Corporation?

Public channels for Zhangjiang Science & Technology Investment Corporation include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Zhangjiang Science & Technology Investment Corporation?

The team at Zhangjiang Science & Technology Investment Corporation includes Sun Weiqin (General Manager). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Zhangjiang Science & Technology Investment Corporation Find emails